Cytosorbents Cash Flow Statement (2011-2026) | CTSO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-4.68M	-6.41M	-9.31M	-8.97M	-10.88M	-12.20M	-0.77M	-7.33M	-6.15M	-9.19M	15.34M	-6.09M	-4.14M	-2.77M	4.16M	-1.48M	-4.23M	-3.17M	-6.50M	-3.90M
Depreciation and Depletion (Quarter)												0.34M	0.46M	0.30M	0.30M	0.31M	0.29M	0.30M	0.30M	0.29M
Share-based Compensation (Quarter)	1.56M	1.00M	0.80M	0.79M	0.76M	1.00M	0.87M	0.83M	0.57M	1.09M	1.67M	0.96M	0.99M	0.89M	0.92M	0.82M	0.57M	0.49M	0.89M	0.54M
Gains from Sales and Divestitures (Quarter)	0.14M	0.20M	0.20M	0.06M	0.04M	0.04M	0.04M		0.08M	0.20M	0.06M		0.02M	0.30M	0.04M	0.07M	0.14M	0.04M	0.07M	0.01M
Gains from Investment Securities (Quarter)	6.86M	0.11M	0.14M	5.80M	0.04M	8.18M		0.33M	0.15M	0.75M	10.55M	0.41M	12.47M	12.51M	8.70M	12.30M	12.20M	12.75M	0.81M	0.05M
Asset Writedowns and Impairment (Quarter)	-0.02M	0.01M	-0.01M	0.01M	0.42M	-0.42M	-0.02M	0.11M	-0.10M	0.00M	0.64M	0.03M	0.22M	0.06M	-0.20M	0.00M	0.25M	-0.08M	-0.14M	0.30M
Non-cash Items (Quarter)	5.99M	5.67M	3.88M	6.07M	4.10M	5.47M	3.88M	3.78M	3.19M	7.99M	4.87M	4.05M	4.42M	3.54M	3.00M	2.27M	0.00M	4.00	1.50M	8.76M
Cash from Operations (Quarter)	-2.04M	-4.13M	-5.49M	-8.12M	-8.04M	-6.73M	-5.34M	-3.11M	-6.93M	-5.21M	-6.41M	-4.83M	-4.79M	-2.46M	-2.34M	-3.46M	-1.51M	-2.58M	-4.83M	-1.16M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			0.40M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.40M	0.05M	0.05M	0.05M	0.13M	0.19M	0.19M	0.19M	-0.44M	0.29M
Depreciation & Amortization (CF) (Quarter)	0.12M	0.24M	0.21M	0.22M	0.23M	0.21M	0.22M	0.26M	0.40M	0.41M	0.39M	0.40M	-0.40M	-0.38M	0.15M	0.37M	-0.40M	-0.36M	0.10M	0.29M
Change in Working Capital
Change in Receivables (Quarter)	0.70M	-0.45M	-0.70M	0.24M	0.70M	-0.08M	0.43M	-0.18M	1.45M	-0.67M	-0.36M	0.85M	1.10M	-1.32M	1.09M	0.08M	-0.34M	-0.30M	0.14M	-0.31M
Change in Inventory (Quarter)	0.61M	1.00M	0.25M	0.83M	-0.24M	-1.05M	-0.49M	-1.75M	0.30M	0.98M	0.29M	0.43M	0.60M	-1.18M	-0.35M	0.20M	0.73M	0.32M	1.29M	-0.72M
Change in Accured Expenses (Quarter)	0.47M	0.19M	2.13M	-1.20M	-1.08M	-0.76M	-0.21M	0.63M	-0.34M	0.76M	0.56M	-1.28M	-0.75M	-1.13M	1.36M	-0.37M	0.01M	0.19M	-0.54M	0.09M
Other Working Capital Changes (Quarter)	0.01M	0.01M	-916.00	0.04M	0.09M	0.16M	1.52M	-0.80M	0.33M	0.44M	1.37M	0.42M	0.55M	0.71M	0.00M	-0.26M	0.19M	0.91M	-0.80M	0.28M
Investing Activities
Capital Expenditures (Quarter)	-0.43M		3.64M	0.71M	-0.48M	0.05M	0.08M	0.51M	-0.21M	0.14M	0.10M	0.05M	0.02M	0.15M	-0.21M	0.00M	0.04M	0.02M	0.11M	0.01M
Change in Intangibles (Quarter)																				0.06M
Sales of Property, Plant and Equipment (Quarter)																				0.03M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)																				-0.05M
Financing Activities
Other financing activities (Quarter)																				0.54M
Cash from Financing Activities (Quarter)	0.13M	0.59M	-0.08M	-0.04M			5.00M	0.68M	0.93M	0.65M	12.21M	-0.57M	9.83M	-0.10M	0.17M	6.83M	-0.00M		2.48M
Additional items
Exchange Rate Effect (Quarter)																				-0.23M
Change in Cash (Quarter)																				-1.44M
Free Cash Flow (Quarter)																				-1.17M
Net Cash Flow (Quarter)																				-1.21M

Research Tools

Cytosorbents Cash Flow Statement (2011-2026) | CTSO

Create an account

Sign In

Reset Password